Joining Alicia Morgans, MD, MPH, is Michael Woods, MD, who is the leader of the Alliance trial A031803, a phase II trial studying how well gemcitabine with pembrolizumab works in treating patients with non-muscle invasive bladder cancer (NMIBC) who are unresponsive to bacillus Calmette-Guérin (BCG). This phase II trial studies the effect of adding pembrolizumab to gemcitabine in treating…
Dan George discusses the CheckMate-67T study with Saby George, a phase three trial comparing intravenous and subcutaneous administration of nivolumab in treatment-refractory kidney cancer patients.…
Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies:…
Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies:…
Hiten Patel discusses his team’s study on the use of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancer. The research, motivated by low utilization…
prostate cancer, Brief Androgen Suppression and Stereotactic Radiation Therapy, High-Risk Prostate Cancer, FASTR trial, FASTR-2 Trials, stereotactic ablative radiotherapy (SABR), SABR in high-risk prostate cancer.
Massimo (Max) Loda discusses his team’s research on the role of the microenvironment in prostate cancer progression, published in Nature Communications. The study focuses on…
prostate cancer, Advanced Prostate Cance, major adverse cardiac events (MACE), HERO study, concomitant Cardiovascular Therapies, Relugolix, Leuprolide, Relugolix versus Leuprolide, concomitant cardiovascular medications (CV), androgen…
InPACT trial, penile cancer, Squamous Cell Cancer of the Penis, Radiotherapy in the Management of Squamous Cell Cancer of the Penis, InPact trial, ECOG-ACRIN, GOG…
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Tian…
Daniel Castellano emphasizes the importance of multidisciplinary approaches in patient care and research. He advocates for precision medicine in genitourinary tumors, highlighting advancements in prostate…
